The goal of this observational study is to learn about the effectiveness of closed-loop spinal cord stimulation (CL-SCS) therapy for treatment of painful chemotherapy induced peripheral neuropathy.
The closed-loop SCS (CL-SCS) system stimulates the nerves in the spinal cord, measures their responses and automatically adjust the stimulation level accordingly in real time for each delivered pulse.
Subject is deemed a suitable candidate for SCS implantation and has been routinely scheduled to undergo an SCS implantation with the Evoke SCS System.
Subject has a minimum of leg or arm pain intensity of 5/10 on the numeric rating scale (NRS) at baseline due to CIPN.
Patients with CIPN following chemotherapy and at least 6 months post-treatment
CIPN symptoms for a minimum duration of 3 months.
Patient refusal to be included in study
Patients unwilling or mentally incapable to complete the study questionnaires
Other causes of neuropathy (for example diabetic- or small fiber neuropathy)
Previous treatment with SCS for CIPN
Rijnstate Hospital
Lead sponsor
Saluda Medical Pty Ltd
Collaborator